Replies to post #1832 on Conatus Pharmaceuticals Inc. (CNAT)

[chainma1l]

Milestone payment would likely put the pps over $10 very quickly.

[lorema]

The new trial include all the participants of the earlier trials an it is a follow up safety trial. While the 15% difference was not achieved on the overall population the subgroup had a higher outcome. There is light on the end of the trial and that’s why the stock is only 30% down and not 90%. Day traders making money...